Aurobindo Pharma Limited (AUROPHARMA.NS) NSE

1,181.90

+14.2(+1.22%)

Updated at January 14 02:56PM

Currency In INR

Valuation

Market Cap661.06B
Enterprise Value661.34B
P/E Ratio20.1
PEG Ratio19.21
Price/Sales Ratio2.12
Price/Book Ratio1.96
Enterprise/Revenue2.08
Enterprise/EBITDA10.1

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.11
Operating Margin0.3

Management Effectiveness

Return On Assets0.07
Return On Equity0.1

Income Statement

Revenue317.24B
Revenue/Share559.82
Gross Profit182.4B
EBITDA64.36B
Net Income34.86B
Diluted EPS59.81

Balance Sheet

Total Cash88.92B
Total Cash/Share153.11
Total Debt77.94B
Total Debt/Equity0.22
Current Ratio1.85
Book Value Per Share603.2

Price History

52-Week Change0.82
52-Week High1,278.6
52-Week Low1,010
Moving Average 50 Days1,198.61
Moving Average 200 Days1,142.94

Statistics

Average Volume1.03M
Shares Outstanding580.8M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate4
Trailing Annual Dividend Yield0.34
Payout Ratio0
Last Split Factor2:1
Last Split DateJuly 20, 2015